Weng et al. [28] compared the KL-6 levels in 69 pSS patients—among them, 59 complicated with ILD and 10 without—and found that KL-6 was one of the factors associated with the presence of ILD in patents with pSS. This evidence concerns the gene MUC1 and interstitial lung disease.